A supplement company defined more by its exclusions than its inclusions. Here's what we won't compromise on, and why.
We make the load-bearing kind.
The supplement industry runs on a quiet trick. Real research, dosed at a fraction of what the studies used. Proprietary blends that hide cheap formulations. Branded actives that disappear after the first ingredient. The marketing borrows credibility from the science. The product rarely earns it.
Imprint exists because we got tired of the gap.
Every formulation we publish lists every ingredient, every dose, every form, and every study we relied on. Clinical doses or we don't include it. Researched forms or we don't make it. No proprietary blends. No hidden math. The whole formula on the front of the bottle because we built it to be read.
If we won't take it ourselves at the labeled dose, we won't sell it. That's the standard.
— What you take in becomes what you leave behind.
The Imprint Standard is built on five concrete commitments. Each one is a constraint we won't break, even when it would be easier or cheaper. These are how a supplement company earns trust.
Every active ingredient in an Imprint formulation is dosed to match the human clinical research behind it. We won't include a "marketing dose" — a sub-therapeutic amount that lets us list the ingredient on the label without delivering the effect. If the studies used 500mg, the bottle contains 500mg.
Most ingredients exist in multiple forms — extracts, isomers, stereoisomers, salts. Most of those forms don't have human research behind them. We use the specific form that was studied in published trials, even when it costs three to ten times more than the commodity equivalent.
Every dose, of every ingredient, in every formulation, listed on the front of the bottle. A "proprietary blend" is the industry's permission slip to hide formulation choices. We don't ask for that permission. If you can't comparison-shop our product against a competitor's, we haven't earned the sale.
Identity, potency, heavy metals, microbial contamination, pesticide residues. Every batch tested by an ISO 17025-accredited independent lab. Every batch number on the bottle links to a downloadable PDF of that batch's complete certificate of analysis. No internal-only testing. No "tested at the factory" wave-of-hand.
Every formulation, the founder takes at the labeled dose, for at least 90 days before launch. If the product doesn't earn its place in our own stack, it doesn't launch. The list of products we've considered and chosen not to release is longer than the list of products we sell.
I'm not a doctor. I'm not a chemist. I'm someone who got obsessive about reading studies and didn't like what I found.
For years, I was buying premium supplements from the brands every health podcast recommends. I assumed the people charging $50 for a bottle of nootropics had done the formulation work. They had — they'd done the marketing work. The dosing was something else.
When I actually pulled up the human trials behind each ingredient and compared them to what was on the labels, the gap was bigger than I expected.
The brands I was buying weren't lying. The labels were technically accurate. But "Bacopa monnieri 100mg" doesn't tell you that the studies showing memory effects used 300mg of a standardized extract for 12 weeks. "Citicoline" doesn't tell you whether you're getting the pharmacologically active CDP-Choline form at the dose the research used. Most labels were optimized to look impressive while costing as little as possible.
I tried buying single-ingredient products from research-grade suppliers and stacking them myself. It worked, but it was eight bottles, $250 a month, and a daily pill routine that felt like a part-time job.
So I started thinking about what a brand built around the actual studies would look like. Not "inspired by science." Not "backed by research." Dosed to the studies. Sourced to the studies. Citation on every ingredient.
That brand didn't exist at any price I could find. So I built it.
Imprint isn't a wellness brand. It isn't a longevity startup. It isn't a vibe. It's a supplement company that publishes its formulation reasoning and dares the rest of the industry to do the same.
If you've ever stared at a supplement label, googled the ingredient, found the original study, and realized you were getting a quarter of the dose the research used — Imprint is for you. I built the stack I couldn't buy.
A brand is also defined by what it refuses to do. These are the industry-standard practices we've ruled out — even when they would be easier or more profitable.
Every dose disclosed. Every form named. The full formulation on the front of the bottle. If the math is on the label, the math is on the label.
We won't include trace amounts of an ingredient just to list it on the label. If the dose isn't enough to do what the studies showed, the ingredient doesn't make the cut.
You won't see phrases like "supports cognitive function" without a specific citation. Every functional claim we make is tied to a published trial we can point you to.
No countdown timers. No "12 people viewing this." No fake scarcity. No popup discount wheels. You'll buy or you won't. We're not going to manipulate the decision.
We won't pay creators with millions of followers to read scripts about our products. Every endorsement on this site is unpaid, voluntary, and verifiable.
We launch one product at a time, get it right, and only release the next when it earns the same standard. The list of products we've decided not to make is longer than the list we sell.
A new Imprint formulation takes 9-14 months from research to bottle. Most of that is research. Some of it is rejection — products that pass three of the five checks but fail the fourth.
We start with the human clinical trials, not the marketing positioning. For every candidate ingredient, we pull the studies, identify the doses used, look for consistency across trials, and check the quality of the methodology. Ingredients that look great in mouse studies but lack human data don't make the shortlist.
Many ingredients have several available forms — extracts, isomers, salts — and most of those forms haven't been tested in humans. We identify which specific form was used in the clinical trials and source that exact form, even when generic alternatives are 3-10× cheaper.
For each ingredient, we evaluate 3-5 suppliers, request certificates of analysis, send samples to a third-party lab for independent verification, and check for contaminant patterns across batches. Suppliers who can't produce clean COAs at scale don't make it past this step.
The founder takes every formulation at the labeled dose for at least 90 days before launch. If the product doesn't earn its place in the founder's own stack, it doesn't ship. This is the most subjective check, but it's the one that's killed the most candidate products.
Once a formulation passes the first four checks, we work with a cGMP-certified manufacturer to produce a pilot batch, send it for third-party identity and potency testing, verify the COA, and only then commit to a production run. The first batch is always small — we'd rather sell out than over-commit.
The Journal is where we publish the reasoning behind every formulation choice. Long-form, citation-heavy, no promotional content. Read it like a research blog, not a marketing channel.